Zenith-Goldline Clozapine Bioequivalence Study Suggested By FDA
Executive Summary
FDA is recommending Zenith-Goldline conduct a bioequivalence study on generic clozapine based on concerns raised by journal publications about the safety and efficacy of its version of the schizophrenia drug.